[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Glycomics & Glycobiology Industry Research Report 2024

April 2024 | 117 pages | ID: GEE572E8FA4BEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics 'is the systematic study of all glycan structures of a given cell type or organism' and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, 'glyco-', and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

According to APO Research, The global Glycomics & Glycobiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glycomics & Glycobiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycomics & Glycobiology.

The Glycomics & Glycobiology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycomics & Glycobiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • ThermoFisher Scientific
  • Danaher
  • Shimadzu Corporation
  • ProZyme
  • Takara Bio, Inc.
  • Agilent Technologies
  • Bruker
  • Promega
  • Waters Corporation
  • R&D Systems
  • New England Biolabs
  • Merck KGaA
Glycomics & Glycobiology segment by Type
  • Instruments
  • Enzymes
  • Reagents
  • Kits
Glycomics & Glycobiology Segment by Application
  • Drug Discovery & Development
  • Diagnostics
  • Others
Glycomics & Glycobiology Segment by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Glycomics & Glycobiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Glycomics & Glycobiology by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
  2.2.2 Instruments
  2.2.3 Enzymes
  2.2.4 Reagents
  2.2.5 Kits
2.3 Glycomics & Glycobiology by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
  2.3.2 Drug Discovery & Development
  2.3.3 Diagnostics
  2.3.4 Others
2.4 Assumptions and Limitations

3 GLYCOMICS & GLYCOBIOLOGY BREAKDOWN DATA BY TYPE

3.1 Global Glycomics & Glycobiology Historic Market Size by Type (2019-2024)
3.2 Global Glycomics & Glycobiology Forecasted Market Size by Type (2025-2030)

4 GLYCOMICS & GLYCOBIOLOGY BREAKDOWN DATA BY APPLICATION

4.1 Global Glycomics & Glycobiology Historic Market Size by Application (2019-2024)
4.2 Global Glycomics & Glycobiology Forecasted Market Size by Application (2019-2024)

5 GLOBAL GROWTH TRENDS

5.1 Global Glycomics & Glycobiology Market Perspective (2019-2030)
5.2 Global Glycomics & Glycobiology Growth Trends by Region
  5.2.1 Global Glycomics & Glycobiology Market Size by Region: 2019 VS 2023 VS 2030
  5.2.2 Glycomics & Glycobiology Historic Market Size by Region (2019-2024)
  5.2.3 Glycomics & Glycobiology Forecasted Market Size by Region (2025-2030)
5.3 Glycomics & Glycobiology Market Dynamics
  5.3.1 Glycomics & Glycobiology Industry Trends
  5.3.2 Glycomics & Glycobiology Market Drivers
  5.3.3 Glycomics & Glycobiology Market Challenges
  5.3.4 Glycomics & Glycobiology Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Glycomics & Glycobiology Players by Revenue
  6.1.1 Global Top Glycomics & Glycobiology Players by Revenue (2019-2024)
  6.1.2 Global Glycomics & Glycobiology Revenue Market Share by Players (2019-2024)
6.2 Global Glycomics & Glycobiology Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Glycomics & Glycobiology Head office and Area Served
6.4 Global Glycomics & Glycobiology Players, Product Type & Application
6.5 Global Glycomics & Glycobiology Players, Date of Enter into This Industry
6.6 Global Glycomics & Glycobiology Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Glycomics & Glycobiology Market Size (2019-2030)
7.2 North America Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Glycomics & Glycobiology Market Size by Country (2019-2024)
7.4 North America Glycomics & Glycobiology Market Size by Country (2025-2030)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Glycomics & Glycobiology Market Size (2019-2030)
8.2 Europe Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Glycomics & Glycobiology Market Size by Country (2019-2024)
8.4 Europe Glycomics & Glycobiology Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Glycomics & Glycobiology Market Size (2019-2030)
9.2 Asia-Pacific Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Glycomics & Glycobiology Market Size by Country (2019-2024)
9.4 Asia-Pacific Glycomics & Glycobiology Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia

10 LATIN AMERICA

10.1 Latin America Glycomics & Glycobiology Market Size (2019-2030)
10.2 Latin America Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Glycomics & Glycobiology Market Size by Country (2019-2024)
10.4 Latin America Glycomics & Glycobiology Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Glycomics & Glycobiology Market Size (2019-2030)
11.2 Middle East & Africa Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2019-2024)
11.4 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE

12 PLAYERS PROFILED

12.1 ThermoFisher Scientific
  12.1.1 ThermoFisher Scientific Company Information
  12.1.2 ThermoFisher Scientific Business Overview
  12.1.3 ThermoFisher Scientific Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
  12.1.5 ThermoFisher Scientific Recent Developments
12.2 Danaher
  12.2.1 Danaher Company Information
  12.2.2 Danaher Business Overview
  12.2.3 Danaher Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.2.4 Danaher Glycomics & Glycobiology Product Portfolio
  12.2.5 Danaher Recent Developments
12.3 Shimadzu Corporation
  12.3.1 Shimadzu Corporation Company Information
  12.3.2 Shimadzu Corporation Business Overview
  12.3.3 Shimadzu Corporation Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
  12.3.5 Shimadzu Corporation Recent Developments
12.4 ProZyme
  12.4.1 ProZyme Company Information
  12.4.2 ProZyme Business Overview
  12.4.3 ProZyme Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
  12.4.5 ProZyme Recent Developments
12.5 Takara Bio, Inc.
  12.5.1 Takara Bio, Inc. Company Information
  12.5.2 Takara Bio, Inc. Business Overview
  12.5.3 Takara Bio, Inc. Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
  12.5.5 Takara Bio, Inc. Recent Developments
12.6 Agilent Technologies
  12.6.1 Agilent Technologies Company Information
  12.6.2 Agilent Technologies Business Overview
  12.6.3 Agilent Technologies Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
  12.6.5 Agilent Technologies Recent Developments
12.7 Bruker
  12.7.1 Bruker Company Information
  12.7.2 Bruker Business Overview
  12.7.3 Bruker Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.7.4 Bruker Glycomics & Glycobiology Product Portfolio
  12.7.5 Bruker Recent Developments
12.8 Promega
  12.8.1 Promega Company Information
  12.8.2 Promega Business Overview
  12.8.3 Promega Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.8.4 Promega Glycomics & Glycobiology Product Portfolio
  12.8.5 Promega Recent Developments
12.9 Waters Corporation
  12.9.1 Waters Corporation Company Information
  12.9.2 Waters Corporation Business Overview
  12.9.3 Waters Corporation Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
  12.9.5 Waters Corporation Recent Developments
12.10 R&D Systems
  12.10.1 R&D Systems Company Information
  12.10.2 R&D Systems Business Overview
  12.10.3 R&D Systems Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
  12.10.5 R&D Systems Recent Developments
12.11 New England Biolabs
  12.11.1 New England Biolabs Company Information
  12.11.2 New England Biolabs Business Overview
  12.11.3 New England Biolabs Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
  12.11.5 New England Biolabs Recent Developments
12.12 Merck KGaA
  12.12.1 Merck KGaA Company Information
  12.12.2 Merck KGaA Business Overview
  12.12.3 Merck KGaA Revenue in Glycomics & Glycobiology Business (2019-2024)
  12.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
  12.12.5 Merck KGaA Recent Developments

13 REPORT CONCLUSION

14 DISCLAIMER



More Publications